Report Detail
Global Contraceptives Drugs Market Insights, Forecast to 2025
- RnM2799343 |
- 23 January, 2019 |
- Global |
- 113 Pages |
- QYResearch |
- Pharma & Healthcare
Contraceptives are a kind of medicine used to prevent unwanted pregnancy. It consists of one or more synthetic female sex hormones. These sex hormones prevent pregnancy by blocking the normal process of ovulation.
The global Contraceptives Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Contraceptives Drugs market based on company, product type, end user and key regions.
This report studies the global market size of Contraceptives Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Contraceptives Drugs in these regions.
This research report categorizes the global Contraceptives Drugs market by top players/brands, region, type and end user. This report also studies the global Contraceptives Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Bayer
Pfizer
Teva Pharmaceutical
Merck
Actavis
Johnson & Johnson
Gedeon Richter
Novo Nordisk A/S
ZiZhu
Baijingyu
Huazhong
Market size by Product
Long-acting Contraceptives
Short-acting Contraceptives
Emergency Contraceptives
Market size by End User
Hospital
Pharmacy
Other
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Contraceptives Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Contraceptives Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Contraceptives Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Contraceptives Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Contraceptives Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Contraceptives Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Contraceptives Drugs Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Contraceptives Drugs Market Size Growth Rate by Product
- 1.4.2 Long-acting Contraceptives
- 1.4.3 Short-acting Contraceptives
- 1.4.4 Emergency Contraceptives
- 1.5 Market by End User
- 1.5.1 Global Contraceptives Drugs Market Size Growth Rate by End User
- 1.5.2 Hospital
- 1.5.3 Pharmacy
- 1.5.4 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Contraceptives Drugs Market Size
- 2.1.1 Global Contraceptives Drugs Revenue 2014-2025
- 2.1.2 Global Contraceptives Drugs Sales 2014-2025
- 2.2 Contraceptives Drugs Growth Rate by Regions
- 2.2.1 Global Contraceptives Drugs Sales by Regions
- 2.2.2 Global Contraceptives Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Contraceptives Drugs Sales by Manufacturers
- 3.1.1 Contraceptives Drugs Sales by Manufacturers
- 3.1.2 Contraceptives Drugs Sales Market Share by Manufacturers
- 3.1.3 Global Contraceptives Drugs Market Concentration Ratio (CR5 and HHI)
- 3.2 Contraceptives Drugs Revenue by Manufacturers
- 3.2.1 Contraceptives Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Contraceptives Drugs Revenue Share by Manufacturers (2014-2019)
- 3.3 Contraceptives Drugs Price by Manufacturers
- 3.4 Contraceptives Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Contraceptives Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Contraceptives Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Contraceptives Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Contraceptives Drugs Sales by Product
- 4.2 Global Contraceptives Drugs Revenue by Product
- 4.3 Contraceptives Drugs Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Contraceptives Drugs Breakdown Data by End User
6 North America
- 6.1 North America Contraceptives Drugs by Countries
- 6.1.1 North America Contraceptives Drugs Sales by Countries
- 6.1.2 North America Contraceptives Drugs Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Contraceptives Drugs by Product
- 6.3 North America Contraceptives Drugs by End User
7 Europe
- 7.1 Europe Contraceptives Drugs by Countries
- 7.1.1 Europe Contraceptives Drugs Sales by Countries
- 7.1.2 Europe Contraceptives Drugs Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Contraceptives Drugs by Product
- 7.3 Europe Contraceptives Drugs by End User
8 Asia Pacific
- 8.1 Asia Pacific Contraceptives Drugs by Countries
- 8.1.1 Asia Pacific Contraceptives Drugs Sales by Countries
- 8.1.2 Asia Pacific Contraceptives Drugs Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Contraceptives Drugs by Product
- 8.3 Asia Pacific Contraceptives Drugs by End User
9 Central & South America
- 9.1 Central & South America Contraceptives Drugs by Countries
- 9.1.1 Central & South America Contraceptives Drugs Sales by Countries
- 9.1.2 Central & South America Contraceptives Drugs Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Contraceptives Drugs by Product
- 9.3 Central & South America Contraceptives Drugs by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Contraceptives Drugs by Countries
- 10.1.1 Middle East and Africa Contraceptives Drugs Sales by Countries
- 10.1.2 Middle East and Africa Contraceptives Drugs Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Contraceptives Drugs by Product
- 10.3 Middle East and Africa Contraceptives Drugs by End User
11 Company Profiles
- 11.1 Bayer
- 11.1.1 Bayer Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Bayer Contraceptives Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Bayer Contraceptives Drugs Products Offered
- 11.1.5 Bayer Recent Development
- 11.2 Pfizer
- 11.2.1 Pfizer Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Pfizer Contraceptives Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Pfizer Contraceptives Drugs Products Offered
- 11.2.5 Pfizer Recent Development
- 11.3 Teva Pharmaceutical
- 11.3.1 Teva Pharmaceutical Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Teva Pharmaceutical Contraceptives Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Teva Pharmaceutical Contraceptives Drugs Products Offered
- 11.3.5 Teva Pharmaceutical Recent Development
- 11.4 Merck
- 11.4.1 Merck Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Merck Contraceptives Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Merck Contraceptives Drugs Products Offered
- 11.4.5 Merck Recent Development
- 11.5 Actavis
- 11.5.1 Actavis Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Actavis Contraceptives Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Actavis Contraceptives Drugs Products Offered
- 11.5.5 Actavis Recent Development
- 11.6 Johnson & Johnson
- 11.6.1 Johnson & Johnson Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Johnson & Johnson Contraceptives Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Johnson & Johnson Contraceptives Drugs Products Offered
- 11.6.5 Johnson & Johnson Recent Development
- 11.7 Gedeon Richter
- 11.7.1 Gedeon Richter Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Gedeon Richter Contraceptives Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Gedeon Richter Contraceptives Drugs Products Offered
- 11.7.5 Gedeon Richter Recent Development
- 11.8 Novo Nordisk A/S
- 11.8.1 Novo Nordisk A/S Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Novo Nordisk A/S Contraceptives Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Novo Nordisk A/S Contraceptives Drugs Products Offered
- 11.8.5 Novo Nordisk A/S Recent Development
- 11.9 ZiZhu
- 11.9.1 ZiZhu Company Details
- 11.9.2 Company Business Overview
- 11.9.3 ZiZhu Contraceptives Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 ZiZhu Contraceptives Drugs Products Offered
- 11.9.5 ZiZhu Recent Development
- 11.10 Baijingyu
- 11.10.1 Baijingyu Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Baijingyu Contraceptives Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Baijingyu Contraceptives Drugs Products Offered
- 11.10.5 Baijingyu Recent Development
- 11.11 Huazhong
12 Future Forecast
- 12.1 Contraceptives Drugs Market Forecast by Regions
- 12.1.1 Global Contraceptives Drugs Sales Forecast by Regions 2019-2025
- 12.1.2 Global Contraceptives Drugs Revenue Forecast by Regions 2019-2025
- 12.2 Contraceptives Drugs Market Forecast by Product
- 12.2.1 Global Contraceptives Drugs Sales Forecast by Product 2019-2025
- 12.2.2 Global Contraceptives Drugs Revenue Forecast by Product 2019-2025
- 12.3 Contraceptives Drugs Market Forecast by End User
- 12.4 North America Contraceptives Drugs Forecast
- 12.5 Europe Contraceptives Drugs Forecast
- 12.6 Asia Pacific Contraceptives Drugs Forecast
- 12.7 Central & South America Contraceptives Drugs Forecast
- 12.8 Middle East and Africa Contraceptives Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Contraceptives Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Contraceptives Drugs . Industry analysis & Market Report on Contraceptives Drugs is a syndicated market report, published as Global Contraceptives Drugs Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Contraceptives Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
